Afe Babalola University

PHA 301: Pharmacology

Practice 573+ past questions for PHA 301 (Pharmacology) at Afe Babalola University. Organized by topic with explanations. Free preview on Testwiz.

573+ questions60 topics300 LevelTheory questionsTopic summaries

Start practicing PHA 301

About PHA 301 at Afe Babalola University

PHA 301 (Pharmacology) is a 300 Level course at Afe Babalola University. Students preparing for PHA 301 exams on Testwiz get 573+ practice questions across 60 topics, including theory questions and topic summaries.

Instead of cramming the night before, students who practice by topic — Pharmacodynamics, Drug Development, Pharmacovigilance, and more — build real familiarity with how Afe Babalola University tests PHA 301, catch weak spots early with Testwiz's analytics, and walk into the exam with actual reps under their belt.

Topics covered

PharmacodynamicsDrug DevelopmentPharmacovigilanceDrug Development and Safety TestingAdverse Drug Reaction Monitoring SystemsPharmacovigilance and ADR ReportingPrinciples of Rational Drug UseManagement of Adverse Drug EffectsConfidentiality in Medical ReportingRational Drug UseAdverse Drug ReactionPharmacodynamics of Full and Partial Agonists+48 more

Sample questions

1. Which of the following BEST describes a partial agonist in relation to a full agonist?

a.It produces a submaximal response even when all receptors are occupied.

b.It binds to the receptor but lacks any intrinsic activity.

c.It acts as a non-competitive antagonist in the absence of a full agonist.

d.It requires a higher concentration to achieve the same maximal effect as a full agonist.

2. Intrinsic activity is a measure of a drug's ability to:

a.Inhibit the binding of an endogenous ligand.

b.Induce a conformational change leading to receptor activation.

c.Bind to a receptor with high affinity.

d.Remain bound to a receptor via covalent interactions.

3. Which clinical trial phase is primarily designed to determine the maximum tolerated dose and safety profile in a small group of healthy volunteers?

a.Phase III

b.Phase I

c.Phase II

d.Phase IV

4. What is the PRIMARY purpose of Phase II clinical trials?

a.To evaluate the drug's effectiveness in patients with the target condition.

b.To perform post-marketing surveillance for rare adverse reactions.

c.To establish the chemical structure and synthesis of the drug.

d.To confirm efficacy in a large, diverse patient population.

5. Which of the following is NOT a standard component of preclinical safety testing?

a.Mutagenicity testing using the Ames test.

b.Assessment of efficacy in a large-scale patient population.

c.Chronic toxicity studies for drugs intended for long-term use.

d.Acute toxicity studies to determine LD50.

Ready for the full PHA 301 question bank?

Get started free

Frequently asked questions

How many PHA 301 past questions are on Testwiz?

Testwiz has 573+ PHA 301 practice questions for Afe Babalola University, organized across 60 topics, including theory questions. Sign up free to start practicing.

Are these past questions free?

Yes, every student gets a free preview of PHA 301 questions on Testwiz. The full question bank, explanations, and weak-spot analytics are available on Pro.

What topics does PHA 301 cover on Testwiz?

PHA 301 on Testwiz covers Pharmacodynamics, Drug Development, Pharmacovigilance, and more. Practice on Testwiz to see the full topic breakdown and sample questions.